Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Bond

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Biochimica Et Biophysica Acta|February 24, 1989
Relationships between chemical structure and inhibition of ADP-stimulated human thrombocyte release of serotonin and platelet factor 4E O Dillingham, A Lasslo, G Carter-Burks, et al.
Research Communications in Chemical Pathology and Pharmacology|December 1, 1992
In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromideB A Lyman, S E Bond, E O Dillingham, et al.
Thrombosis Research|February 15, 1993
Enantioselective antiplatelet actions of nipecotamidesR Gollamudi, Z Feng, E O Dillingham, et al.
General Pharmacology|November 1, 1994
Synergistic antiplatelet effects of a nipecotamide A-1C and low dose aspirinG Han, S E Bond, W H Lawrence, et al.
Biochimica Et Biophysica Acta|August 7, 1989
Relationships between chemical structure and inhibition of epinephrine-induced human blood platelet aggregationJ Petrusewicz, A Lasslo, G Carter-Burks, et al.
The Journal of Hospital Infection|January 30, 2017
The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan settingS E Bond, C S Boutlis, W W Yeo, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1995
Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomidesD Herron, E O Dillingham, B A Lyman, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancerS Subramanyan, M D Abeloff, S E Bond, et al.
Journal of Medicinal Chemistry|January 6, 1995
Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitorsX Zheng, S R Salgia, W B Thompson, et al.
Journal of Medicinal Chemistry|August 7, 1992
Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidinesZ Feng, R Gollamudi, E O Dillingham, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biochimica Et Biophysica Acta|February 24, 1989
Relationships between chemical structure and inhibition of ADP-stimulated human thrombocyte release of serotonin and platelet factor 4E O Dillingham, A Lasslo, G Carter-Burks, et al.
Research Communications in Chemical Pathology and Pharmacology|December 1, 1992
In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromideB A Lyman, S E Bond, E O Dillingham, et al.
Thrombosis Research|February 15, 1993
Enantioselective antiplatelet actions of nipecotamidesR Gollamudi, Z Feng, E O Dillingham, et al.
General Pharmacology|November 1, 1994
Synergistic antiplatelet effects of a nipecotamide A-1C and low dose aspirinG Han, S E Bond, W H Lawrence, et al.
Biochimica Et Biophysica Acta|August 7, 1989
Relationships between chemical structure and inhibition of epinephrine-induced human blood platelet aggregationJ Petrusewicz, A Lasslo, G Carter-Burks, et al.
The Journal of Hospital Infection|January 30, 2017
The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan settingS E Bond, C S Boutlis, W W Yeo, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1995
Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomidesD Herron, E O Dillingham, B A Lyman, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancerS Subramanyan, M D Abeloff, S E Bond, et al.
Journal of Medicinal Chemistry|January 6, 1995
Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitorsX Zheng, S R Salgia, W B Thompson, et al.
Journal of Medicinal Chemistry|August 7, 1992
Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidinesZ Feng, R Gollamudi, E O Dillingham, et al.
Pageof 2